Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Use of Manufacturing Control Systems – V 2.0

Posted on By

Elixir Department: SOP for Use of Manufacturing Control Systems – V 2.0

Standard Operating Procedure for Use of Manufacturing Control Systems in Elixir Production

Department Elixir Department
SOP No. SOP/ELX/075/2025
Supersedes SOP/ELX/075/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a systematic approach for the use, monitoring, and documentation of electronic and automated Manufacturing Control Systems (MCS) used in the production of elixirs to ensure process reliability, traceability, and compliance with GMP.

2. Scope

This SOP applies to all programmable logic controllers (PLC), Human Machine Interfaces (HMI), SCADA systems, and other digital controls used in the Elixir Department for mixing, heating, cooling, volume adjustment, and agitation.

3. Responsibilities

  • Production Operator:
    • Operate the MCS as per validated procedures and authorized access levels.
    • Document system alerts, setpoint deviations, or alarms promptly.
  • Production Supervisor:
    • Ensure system calibration, backups, and audit trail functionality are in place.
  • QA Officer:
    • Verify logs, user permissions, and review audit trails periodically.
  • Engineering Department:
    • Maintain system integrity, perform troubleshooting, and ensure data security.
See also  Elixir Department: SOP for Transfer of Dispensed Materials to Manufacturing Area - V 2.0

4. Accountability

The Head of Production and the Head of Engineering are jointly accountable for ensuring correct

usage, maintenance, and validation of the manufacturing control systems.

5. Procedure

5.1 System Access and Authorization

  1. Only trained personnel with valid usernames and passwords shall operate the MCS.
  2. User roles (e.g., Operator, Supervisor, Administrator) shall be defined and access restricted accordingly.
  3. Change control must be initiated for any modification in user access or system configuration.

5.2 Operation of MCS

  1. Follow the sequence of operation displayed on HMI or SCADA screens.
  2. Set process parameters as per BMR or approved recipe (e.g., temperature, agitation speed, duration).
  3. Review system feedback and ensure critical values are within the specified range before proceeding.

See also  Elixir Department: SOP for Use of Water for Injection (WFI) in Elixir Production - V 2.0

5.3 Data Logging and Documentation

  1. System shall record process data automatically and generate digital or printed logs.
  2. Backups of process data must be scheduled daily or at the end of each batch.
  3. Operators must sign printed logs and attach them to the BMR for traceability.

5.4 Alarms and Deviation Handling

  1. In case of deviation or alarm:
    • Stop the process (if critical), inform supervisor and QA immediately.
    • Record event code, time, and deviation details in the MCS Alarm Log (Annexure-1).
    • Raise deviation report if required.

5.5 System Maintenance and Calibration

  1. Engineering must verify:
    • Touch screen calibration, sensor accuracy, and communication between components.
    • System validation annually or after major software/hardware changes.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • MCS: Manufacturing Control System
  • HMI: Human Machine Interface
  • PLC: Programmable Logic Controller
  • SCADA: Supervisory Control and Data Acquisition

7. Documents

  1. MCS Alarm Log (Annexure-1)
  2. System Access Authorization Log (Annexure-2)
  3. Process Parameter Printout (attached to BMR)
See also  Elixir Department: SOP for Operation of Transfer Pumps - V 2.0

8. References

  • 21 CFR Part 11 – Electronic Records and Signatures
  • WHO Annex 5 – Validation of Computerized Systems
  • GAMP 5 – Good Automated Manufacturing Practice

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: MCS Alarm Log

Date Batch No. Alarm Code Description Action Taken Operator
11/04/2025 ELX-1015 E01 Temperature Exceeded Agitation stopped, QA informed Rajesh Kumar

Annexure-2: System Access Authorization Log

Employee Name User ID Role Authorized By Date
Sunita Reddy SREDDY Supervisor Production Head 10/04/2025

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New Implementation QA Head
11/04/2025 2.0 Included SCADA and Audit Trail Management Compliance Enhancement QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Gel Manufacturing: SOP for Using Vacuum Deaerators in Gel Manufacturing – V 2.0
Next Post: API Manufacturing: SOP for Reanalysis Protocol for Failed Samples – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version